Drug hypersensitivity in the fast lane: What clinicians should know about phenotypes, endotypes, and biomarkers. Miércoles 29 de julio
Drug hypersensitivity in the fast lane: What clinicians should know about phenotypes, endotypes, and biomarkers Authors: Baruch D Jakubovic 1 , Leticia de Las Vecillas 2 , Teodorikez Wilfox Jimenez-Rodriguez 3 , Soledad Sanchez-Sanchez 4 , Mariana Castells 5 Abstract Objective: To review novel concepts in drug hypersensitivity and the management of immediate hypersensitivity reactions. Data sources: English language literature on MEDLINE and Embase surrounding drug hypersensitivity and desensitization. Study selections: References were selected based on relevance, date of publication, and originality. Results: There are numerous citations looking at categorizing drug reactions, pathogenesis, biomarkers, and desensitization. Current understanding supports the use of a phenotype-endotype-biomarker model for categorizing immediate hypersensitivity reactions. Drug desensitization is a powerful therapeutic strategy that enables temporary induction of...